Change of Serum Biomarkers to Post-Thrombolytic Symptomatic Intracranial Hemorrhage in Stroke

BackgroundSymptomatic intracranial hemorrhage (sICH) is a terrible complication after intravenous alteplase in stroke, and numerous biomarkers have been investigated. However, the change of biomarkers to sICH has not been well determined.AimTo investigate the association between the change of biomar...

Full description

Bibliographic Details
Main Authors: Yu Cui, Xin-Hong Wang, Yong Zhao, Shao-Yuan Chen, Bao-Ying Sheng, Li-Hua Wang, Hui-Sheng Chen
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Neurology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2022.889746/full
_version_ 1811245003541839872
author Yu Cui
Xin-Hong Wang
Yong Zhao
Shao-Yuan Chen
Bao-Ying Sheng
Li-Hua Wang
Hui-Sheng Chen
author_facet Yu Cui
Xin-Hong Wang
Yong Zhao
Shao-Yuan Chen
Bao-Ying Sheng
Li-Hua Wang
Hui-Sheng Chen
author_sort Yu Cui
collection DOAJ
description BackgroundSymptomatic intracranial hemorrhage (sICH) is a terrible complication after intravenous alteplase in stroke, and numerous biomarkers have been investigated. However, the change of biomarkers to sICH has not been well determined.AimTo investigate the association between the change of biomarkers and sICH.MethodsThis is a prospective cohort study, and patients with sICH within 24 h after thrombolysis were enrolled, while patients without sICH were matched by propensity score matching with a ratio of 1:1. The blood samples were collected before and 24 h after intravenous thrombolysis (IVT), and preset 49 serum biomarkers were measured by microarray analysis. Protein function enrichment analyses were performed to detect the association between the change of biomarkers and sICH.ResultsOf consecutive 358 patients, 7 patients with sICH in 24 h were assigned to the sICH group, while 7 matched patients without any ICH were assigned to the non-sICH group. A total of 9 biomarkers were found to significantly change before vs. after thrombolysis between groups, including increased biomarkers, such as brain-derived neurotrophic factor, C-C motif chemokine ligand (CCL)-24, interleukin (IL)-6, IL-10, IL-18, and vascular endothelial growth factor, and decreased biomarkers, such as CCL-11, intercellular adhesion molecule-1, and IL-7.ConclusionsThis is the first study to identify changes in serum biomarkers in patients with sICH after IVT, and found that 6 neuroinflammatory and 3 neuroprotective biomarkers may be associated with brain injury following post-thrombolytic sICH.Clinical Trial Registrationhttps://www.clinicaltrials.gov, identifier: NCT02854592.
first_indexed 2024-04-12T14:33:37Z
format Article
id doaj.art-bd568fe98a26490e856abcefa88b50eb
institution Directory Open Access Journal
issn 1664-2295
language English
last_indexed 2024-04-12T14:33:37Z
publishDate 2022-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Neurology
spelling doaj.art-bd568fe98a26490e856abcefa88b50eb2022-12-22T03:29:11ZengFrontiers Media S.A.Frontiers in Neurology1664-22952022-06-011310.3389/fneur.2022.889746889746Change of Serum Biomarkers to Post-Thrombolytic Symptomatic Intracranial Hemorrhage in StrokeYu Cui0Xin-Hong Wang1Yong Zhao2Shao-Yuan Chen3Bao-Ying Sheng4Li-Hua Wang5Hui-Sheng Chen6Department of Neurology, General Hospital of Northern Theatre Command, Shenyang, ChinaDepartment of Neurology, General Hospital of Northern Theatre Command, Shenyang, ChinaDepartment of Neurology, Haicheng Hospital of Traditional Chinese Medicine, Haicheng, ChinaDepartment of Neurology, Chinese People's Liberation Army 321 Hospital, Baicheng, ChinaDepartment of Neurology, Jiamusi University First Affiliated Hospital, Jiamusi, ChinaDepartment of Neurology, The Second Affiliated Hospital of Harbin Medical University, Harbin, ChinaDepartment of Neurology, General Hospital of Northern Theatre Command, Shenyang, ChinaBackgroundSymptomatic intracranial hemorrhage (sICH) is a terrible complication after intravenous alteplase in stroke, and numerous biomarkers have been investigated. However, the change of biomarkers to sICH has not been well determined.AimTo investigate the association between the change of biomarkers and sICH.MethodsThis is a prospective cohort study, and patients with sICH within 24 h after thrombolysis were enrolled, while patients without sICH were matched by propensity score matching with a ratio of 1:1. The blood samples were collected before and 24 h after intravenous thrombolysis (IVT), and preset 49 serum biomarkers were measured by microarray analysis. Protein function enrichment analyses were performed to detect the association between the change of biomarkers and sICH.ResultsOf consecutive 358 patients, 7 patients with sICH in 24 h were assigned to the sICH group, while 7 matched patients without any ICH were assigned to the non-sICH group. A total of 9 biomarkers were found to significantly change before vs. after thrombolysis between groups, including increased biomarkers, such as brain-derived neurotrophic factor, C-C motif chemokine ligand (CCL)-24, interleukin (IL)-6, IL-10, IL-18, and vascular endothelial growth factor, and decreased biomarkers, such as CCL-11, intercellular adhesion molecule-1, and IL-7.ConclusionsThis is the first study to identify changes in serum biomarkers in patients with sICH after IVT, and found that 6 neuroinflammatory and 3 neuroprotective biomarkers may be associated with brain injury following post-thrombolytic sICH.Clinical Trial Registrationhttps://www.clinicaltrials.gov, identifier: NCT02854592.https://www.frontiersin.org/articles/10.3389/fneur.2022.889746/fullalteplaseintravenous thrombolysissymptomatic intracranial hemorrhagebiomarkersmicroarray analysis
spellingShingle Yu Cui
Xin-Hong Wang
Yong Zhao
Shao-Yuan Chen
Bao-Ying Sheng
Li-Hua Wang
Hui-Sheng Chen
Change of Serum Biomarkers to Post-Thrombolytic Symptomatic Intracranial Hemorrhage in Stroke
Frontiers in Neurology
alteplase
intravenous thrombolysis
symptomatic intracranial hemorrhage
biomarkers
microarray analysis
title Change of Serum Biomarkers to Post-Thrombolytic Symptomatic Intracranial Hemorrhage in Stroke
title_full Change of Serum Biomarkers to Post-Thrombolytic Symptomatic Intracranial Hemorrhage in Stroke
title_fullStr Change of Serum Biomarkers to Post-Thrombolytic Symptomatic Intracranial Hemorrhage in Stroke
title_full_unstemmed Change of Serum Biomarkers to Post-Thrombolytic Symptomatic Intracranial Hemorrhage in Stroke
title_short Change of Serum Biomarkers to Post-Thrombolytic Symptomatic Intracranial Hemorrhage in Stroke
title_sort change of serum biomarkers to post thrombolytic symptomatic intracranial hemorrhage in stroke
topic alteplase
intravenous thrombolysis
symptomatic intracranial hemorrhage
biomarkers
microarray analysis
url https://www.frontiersin.org/articles/10.3389/fneur.2022.889746/full
work_keys_str_mv AT yucui changeofserumbiomarkerstopostthrombolyticsymptomaticintracranialhemorrhageinstroke
AT xinhongwang changeofserumbiomarkerstopostthrombolyticsymptomaticintracranialhemorrhageinstroke
AT yongzhao changeofserumbiomarkerstopostthrombolyticsymptomaticintracranialhemorrhageinstroke
AT shaoyuanchen changeofserumbiomarkerstopostthrombolyticsymptomaticintracranialhemorrhageinstroke
AT baoyingsheng changeofserumbiomarkerstopostthrombolyticsymptomaticintracranialhemorrhageinstroke
AT lihuawang changeofserumbiomarkerstopostthrombolyticsymptomaticintracranialhemorrhageinstroke
AT huishengchen changeofserumbiomarkerstopostthrombolyticsymptomaticintracranialhemorrhageinstroke